Amy Wendell - Mar 3, 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: Director
Signature: /s/ Marc Began, as attorney-in-fact for Amy Wendell
Stock symbol: AXGN
Transactions as of: Mar 3, 2025
Transactions value $: -$100,100
Form type: 4
Date filed: 3/5/2025, 06:20 PM
Previous filing: Feb 28, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Sale	-$100K	-5K	-4.86%	$20.02	97.9K	Mar 3, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares were sold pursuant to an Approved Rule 10b5-1 Plan, as defined under the Company's Insider Trading Policy.
F2	The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported shares were sold pursuant to an Approved Rule 10b5-1 Plan, as defined under the Company's Insider Trading Policy.

The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.